ASYMCHEM LAB.(TIAN.)H YC1 Cash Flow-to-Debt Ratio
ASYMCHEM LAB.(TIAN.)H YC1 cash flow-to-debt ratio. ASYMCHEM LAB.(TIAN.)H YC1 (7K90) has a Cash Flow-to-Debt Ratio of 0.53x as of December 2025, meaning its operating cash flow of €1.41 Billion could theoretically repay 1% of its total liabilities (€2.63 Billion) in one year. Check ASYMCHEM LAB.(TIAN.)H YC1 (7K90) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ASYMCHEM LAB.(TIAN.)H YC1 (2021–2025)
Cash flow-to-debt ratio of ASYMCHEM LAB.(TIAN.)H YC1 from 2021 to 2025. Historical debt coverage capacity for ASYMCHEM LAB.(TIAN.)H YC1 across 5 annual periods. Check 7K90 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
ASYMCHEM LAB.(TIAN.)H YC1 Cash Flow-to-Debt Ratio by Year (2021–2025)
ASYMCHEM LAB.(TIAN.)H YC1 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for ASYMCHEM LAB.(TIAN.)H YC1. For the full cash flow conversion analysis, see ASYMCHEM LAB.(TIAN.)H YC1 operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.53x | €1.41 Billion | €2.63 Billion | ▲ +3.5% |
| 2024 | 0.52x | €1.25 Billion | €2.43 Billion | ▼ -67.1% |
| 2023 | 1.57x | €3.55 Billion | €2.26 Billion | ▲ +21.7% |
| 2022 | 1.29x | €3.29 Billion | €2.54 Billion | ▲ +2807.2% |
| 2021 | 0.04x | €113.15 Million | €2.55 Billion | — |